Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
Kona SUV: Exploring the Future with Hyundai's Visionary Hybrid- American Airlines Flight Attendant Disappears Amid Layover in Colombia, Authorities Investigating
- Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- Vote In favor of Your Favored Kind Of Tea
- Defence chiefs of Thailand and Cambodia to discuss ceasefire
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Instructions to Boost Your True capacity with a Brain research Degree
- 6 Web-based Course Stages for Successful Learning and Educating
